3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
37
Liver Neoplasms
18
Neoplasm Metastasis
17
Colorectal Neoplasms
13
Cholangiocarcinoma
11
Pancreatic Neoplasms
9
Lung Neoplasms
8
Colonic Neoplasms
8
Breast Neoplasms
8
Barrett Esophagus
7
Recurrence
6
Carcinoma, Renal Cell
6
Carcinoma, Non-Small-Cell Lung
6
Thyroid Neoplasms
5
Rectal Neoplasms
5
Thyroid Nodule
4
Pain
4
Neoplasms
4
Kidney Neoplasms
4
Esophageal Neoplasms
4
Thyroid Cancer, Papillary
3
Biliary Tract Neoplasms
3
Agnosia
3
Thyroid Diseases
2
Prostatic Neoplasms
2
Leiomyoma
2
Hyperaldosteronism
2
Cancer Pain
2
Bile Duct Neoplasms
2
Uterine Cervical Neoplasms
1
Interventions
Bevacizumab
2
regorafenib
1
Radiofrequency Ablation
1
PSMA-BCH
1
Oxaliplatin
1
IFL protocol
1
FOLFOXIRI protocol
1
Electroporation
1
Cetuximab
1
CPG-oligonucleotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liver Metastasis Colon Cancer
×
Radiofrequency Ablation
×
Clear all
NCT04798898
2024-12-05
ISCOLIM
University of Aarhus
Phase NA
Recruiting
200 enrolled